Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Psychiatry

• Publication date

  2011-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1176/appi.ajp.2011.11030516PMID 22193673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.

  2011cited by this paper
• Disease-relevant autoantibodies in first episode schizophrenia

  2010cited by this paper
• Antibodies and neuronal autoimmune disorders of the CNS

  2010cited by this paper
• High prevalence of autoantibodies against phosphoglycerate mutase 1 in patients with autoimmune central nervous system diseases.

  2010cited by this paper
• Psychiatric manifestations of paraneoplastic disorders.

  2010cited by this paper
• Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy.

  2010cited by this paper
• Autoimmune diseases, bipolar disorder, and non-affective psychosis.

  2010cited by this paper
• The association of infectious agents and schizophrenia

  2010cited by this paper
• Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction.

  2010cited by this paper
• Prenatal infection and schizophrenia: a review of epidemiologic and translational studies.

  2010cited by this paper
• Losing your nerves? Maybe it's the antibodies

  2009cited by this paper
• Immune involvement in schizophrenia and autism: etiology, pathology and animal models.

  2009cited by this paper
• Psychiatric disorder as a first manifestation of cancer: A 10‐year population‐based study

  2009cited by this paper
• Selected infectious agents and risk of schizophrenia among U.S. military personnel.

  2008cited by this paper
• Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects.

  2008cited by this paper
• Autoantibody-mediated disorders of the central nervous system

  2008cited by this paper
• Autoantibody reactivity in serum of patients with major depression, schizophrenia and healthy controls.

  2008cited by this paper
• Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions.

  2008cited by this paper
• Are some cases of psychosis caused by microbial agents? A review of the evidence

  2008cited by this paper
• Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

  2007cited by this paper
• Neuroimmunopathology in a murine model of neuropsychiatric lupus.

  2007cited by this paper
• Autoantibodies associated with psychiatric disorders.

  2006cited by this paper
• The Danish Civil Registration System. A cohort of eight million persons.

  2006cited by this paper
• Association of schizophrenia and autoimmune diseases: linkage of Danish national registers.

  2006cited by this paper
• Molecular mimicry: anti-DNA antibodies bind microbial and nonnucleic acid self-antigens.

  2005cited by this paper
• Immune dysregulation and self‐reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis?

  2005cited by this paper
• Parental socio-economic status and risk of first admission with schizophrenia

  2004cited by this paper
• Cognition and immunity; antibody impairs memory.

  2004cited by this paper
• Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders.

  2003cited by this paper
• The Danish National Hospital Register. A valuable source of data for modern health sciences.

  1999cited by this paper
• Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases.

  1998cited by this paper
• Biologic synergism and parallelism.

  1997cited by this paper
• The Danish Psychiatric Central Register.

  1997cited by this paper
• Basic problems in interaction assessment.

  1993cited by this paper
• Estimating the population attributable risk for multiple risk factors using case-control data.

  1985cited by this paper

• Identification of metabolism and inflammation-related biomarkers and potential drugs for schizophrenia based on comprehensive bioinformatics and machine learning.

  2026cites this paper
• From Genome-Wide SNPs to Neuroimmune Crosstalk: Mapping the Genetic Landscape of IBD and Its Brain Overlap

  2025cites this paper
• Neuroglial responses to bacterial, viral, and fungal neuroinfections.

  2025cites this paper
• Associations of migrant and refugee status with physical comorbidity and mortality among young adults with incident non-affective psychotic disorders

  2025cites this paper
• Autoimmune neuropsychiatric disorders manifesting with psychosis

  2025cites this paper
• Pro-inflammatory processes and metabolic syndrome: combined risk of resistance to treatment in patients with schizophrenia from the FACE-SZ cohort.

  2025cites this paper
• Evaluation of Inflammatory Markers in Perception Disorders in Major Psychiatric Pathology

  2025cites this paper
• Neuroimmune mechanisms of neurodevelopmental disorders.

  2025cites this paper
• Involvement of virus infections and antiviral agents in schizophrenia

  2025cites this paper
• The Immune/Inflammatory Underpinnings of Neurodevelopmental Disorders and Pediatric Acute-Onset Neuropsychiatric Syndrome: A Scoping Review

  2025cites this paper
• Investigation of peripheral markers of inflammation in patients with different diagnoses on the psychosis spectrum: an observational cross-sectional study

  2025cites this paper
• HMG‐CoA reductase inhibitors (statins) versus placebo for people with schizophrenia

  2025cites this paper
• Systematic Multi‐Trait Study of Genetic Correlation and Causality Relationships Between General Medical Conditions and Mental Disorders

  2025cites this paper
• Probiotics, psychobiotics, and postbiotics: a therapeutic modality for the management of schizophrenia

  2025cites this paper
• High-sensitivity C-reactive protein as a mediator between sleep quality and mental health in first-degree relatives of individuals with schizophrenia

  2025cites this paper
• Cardiovascular protein profiling in patients with first-episode psychosis

  2025cites this paper
• Autoimmune problems of resistant schizophrenia: Lessons from rheumatology

  2025cites this paper
• Gut microbiota dysbiosis at the interface of neuropsychiatric disorders and their dermatological comorbidities

  2025cites this paper
• Neuropharmacological targets for schizophrenia treatment: An update.

  2025cites this paper
• Integrative transcriptomic and proteomic analysis reveals that SERPING1 inhibits neuronal proliferation via the CaMKII-CREB-BDNF pathway in schizophrenia

  2025cites this paper
• Effect of olanzapine on changes in serum complement factors levels in patients with first-episode schizophrenia

  2025cites this paper
• Limited evidence of association between dysregulated immune marker levels and telomere length in severe mental disorders

  2025cites this paper
• Autoantibodies in patients with 22q11.2 deletion syndrome and psychosis.

  2025cites this paper
• Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis

  2025cites this paper
• Integrative GWAS and Mendelian randomization study of rheumatoid arthritis based on the 2019 UK Biobank questionnaire

  2025cites this paper
• Minor immunomodulatory effects of psychotropics suggested in severe mental disorders: Associations of antipsychotics with beta defensin 2, antidepressants with C-reactive protein, and mood stabilizers with soluble interleukin 2 receptor

  2025cites this paper
• Inflammation manipulation and a complement-centered reboot of the Toxoplasma gondii model of schizophrenia.

  2025cites this paper
• Neural autoantibodies in psychiatric disorders are associated with antibodies against viral pathogens: a retrospective study of 619 patients

  2025cites this paper
• Differences in Blood Leukocyte Subpopulations in Schizophrenia: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Oro-pharyngeal mucosal microbiome alternations causing immune system dysregulation in schizophrenia.

  2025cites this paper
• Bridging Environmental Exposures and Brain Health with an Integrative Framework for Understanding Neurobiological Impacts.

  2025cites this paper
• Molecular and Functional Analysis of TLR 1, 2 and 6 in Peripheral Blood Monocytes of Patients with Schizophrenia: A Pilot Study

  2025cites this paper
• Autoantibodies and Inflammation in Schizophrenia

  2025cites this paper
• Synaptic Pruning in Schizophrenia: Manifestations and Antecedents

  2025cites this paper
• Unveiling genetic and biological links: exploring the intersection of autoimmune and psychiatric disorders

  2025cites this paper
• Mental Ill-Health in young people with systemic autoinflammatory disease – a scoping review

  2025cites this paper
• Identification of specific brain cell types associated with the interplay between inflammatory bowel diseases and neuropsychiatric disorders by Cell-Stratified Mendelian Randomisation

  2025cites this paper
• Genetic evidence for a neuro-immune model of schizophrenia.

  2025cites this paper
• Neuropsychiatric Manifestations of Lyme Disease: A Literature Review of Psychiatric and Cognitive Impacts

  2025cites this paper
• Impact of second-generation antipsychotics monotherapy or combined therapy in cytokine, lymphocyte subtype, and thyroid antibodies for schizophrenia: a retrospective study

  2024cites this paper
• Bidirectional two-sample Mendelian randomization study of differential white blood cell counts and schizophrenia.

  2024cites this paper
• Systematic evaluation of the associations between schizophrenia and autoimmune diseases: An umbrella review.

  2024cites this paper
• Soluble terminal complement complex blood levels are elevated in schizophrenia

  2024cites this paper
• Depression and risk of infectious diseases: A mendelian randomization study

  2024cites this paper
• Lower risk of hospitalisation for depression following hospitalisation for COVID-19 versus for another reason.

  2024cites this paper
• Neuropsychiatric Systemic Lupus Erythematosus in a Patient with Pancytopenia and Chronic Schizophrenia Requiring Hospitalisation

  2024cites this paper
• Identifying independent causal cell types for human diseases and risk variants

  2024cites this paper
• Inflammation Proteomic Profiling of Psychosis in Young Adults: findings from the ALSPAC birth cohort

  2024cites this paper
• Modulation of neuroinflammation and oxidative stress by targeting GPR55 – new approaches in the treatment of psychiatric disorders

  2024cites this paper
• Exploring the Psychiatric Manifestations of Primary Sjögren's Syndrome: A Narrative Review

  2024cites this paper
• The relationship between schizophrenia or schizoaffective disorder and type 1 diabetes mellitus: a scoping review of observational studies

  2024influential citation
• Regulation of Zbp1 by miR-99b-5p in microglia controls the development of schizophrenia-like symptoms in mice

  2024cites this paper
• Multiple serum anti-glutamate receptor antibody levels in clozapine-treated/naïve patients with treatment-resistant schizophrenia

  2024cites this paper
• The role of infections and inflammation in schizophrenia: review of the evidence

  2024cites this paper
• Neuroinflammation and schizophrenia – is there a link?

  2024cites this paper
• Attıtudes of Female Employees In Nutrıtıon of 9 Months-6 Years Old Chıldren In Covıd-19

  2024cites this paper
• Peripheral blood complement factors C2 and C3 as biomarkers of clinical efficacy in patients with first-episode schizophrenia after aripiprazole treatment

  2024cites this paper
• Causality between autoimmune diseases and schizophrenia: a bidirectional Mendelian randomization study

  2024cites this paper
• Psychosis Associated With Hyperglycemia in a Female Patient With Type 1 Diabetes Mellitus: A Case Report

  2024cites this paper
• Dysfunction of olfactory structures: A conserved mechanism of neurodegeneration?

  2024cites this paper
• Causal role of immune cells in major depressive disorder and bipolar disorder: Mendelian randomization (MR) study.

  2024cites this paper
• The potential role of miRNAs in the pathogenesis of schizophrenia - A focus on signaling pathways interplay.

  2024cites this paper
• Immune Cell Alterations in Psychotic Disorders: A Comprehensive Systematic Review and Meta-analysis.

  2024cites this paper
• Prevalence and Risk of Schizophrenia and Bipolar Disorder in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis

  2024cites this paper
• Relationship between blood-cerebrospinal fluid barrier integrity, cardiometabolic, and inflammatory factors in schizophrenia-spectrum disorders

  2024cites this paper
• The causal relationship between immune cell traits and schizophrenia: a Mendelian randomization analysis

  2024cites this paper
• Associations between physical diseases and subsequent mental disorders: a longitudinal study in a population‐based cohort

  2024cites this paper
• Proteomic analysis of peripheral blood mononuclear cells in first episode psychosis - Protein and peptide-centered approaches to elucidate potential diagnostic biomarkers.

  2024cites this paper
• Prenatal and early childhood infections requiring hospitalization and risk of neurodevelopmental disorders in offspring: a population-based birth cohort study in Taiwan

  2024cites this paper
• The researcher's guide to selecting biomarkers in mental health studies

  2024cites this paper
• Protein Profiles and Novel Molecular Biomarkers of Schizophrenia Based on 4D-DIA Proteomics.

  2024cites this paper
• Risks of developing major psychiatric disorders among child and adolescent intensive care unit survivors.

  2024cites this paper
• Is the acquired hypothyroidism a risk factor for developing psychiatric disorders?

  2024cites this paper
• Association of serum interleukin-6 with negative symptoms in stable early-onset schizophrenia

  2024cites this paper
• Multimorbidity and the Etiology of Schizophrenia

  2024cites this paper
• Associations Between Mental Disorders in Donors and Matched Recipients of Hematopoietic Stem Cell Transplants: A Population-Based Cohort Study

  2024cites this paper
• Glycocalyx shedding patterns identifies antipsychotic-naïve patients with first-episode psychosis.

  2024cites this paper
• How delusions can uncover sources of harm and pathology: The epistemic value of interoceptive and unconscious information

  2024cites this paper
• The Discovery of a Fourth Meninges: Potential Implications for Brain Disorders.

  2023cites this paper
• A rare case of schizophrenia coexistence with antiphospholipid syndrome, β-thalassemia, and monoclonal gammopathy of undetermined significance

  2023cites this paper
• Schizophrenia, Human Leukocyte Antigen (HLA), and Herpes Viruses: Immunogenetic Associations at the Population Level

  2023cites this paper
• Neuron-Microglia Crosstalk in Neuropsychiatric Disorders.

  2023cites this paper
• An examination of plasma autoantibodies against voltage gated calcium channels in schizophrenia

  2023cites this paper
• Association between autoimmune diseases of the nervous system and schizophrenia: A systematic review and meta-analysis of cohort studies.

  2023cites this paper
• Publishing Negative Results of Neurobiological Studies in Mental Disorders Will Advance Knowledge in Pathophysiology.

  2023cites this paper
• Severe Mental Illness Among Adults with Atopic Eczema or Psoriasis: Population-Based Matched Cohort Studies within UK Primary Care

  2023cites this paper
• COVID-19 and New-Onset Psychosis: A Comprehensive Review

  2023cites this paper
• Patients with schizophrenia and bipolar disorder display a similar global gene expression signature in whole blood that reflects elevated proportion of immature neutrophil cells with association to lipid changes

  2023cites this paper
• Genetic and epidemiological analyses of infection load and its relationship with psychiatric disorders

  2023cites this paper
• The role of immune inflammation in electroconvulsive therapy for schizophrenia: Treatment mechanism, and relationship with clinical efficacy: Immune-inflammation in ECT for schizophrenia.

  2023cites this paper
• Urbanicity and psychotic disorders: Facts and hypotheses

  2023cites this paper
• Risk of Schizophrenia in Patients with Psoriasis: A Systematic Review and Meta‐Analysis

  2023cites this paper
• Schizophrenia Etiological Factors and Their Correlation with the Imbalance of the Immune System: An Update

  2023influential citation
• Toll-Like Receptor (TLR) 1, 2, and 6 Gene Polymorphisms Support Evidence of Innate Immune Factors in Schizophrenia

  2023cites this paper
• Immunological Biomarkers as Predictors of Treatment Response in Psychotic Disorders

  2023cites this paper
• The immunomodulatory effect of lithium as a mechanism of action in bipolar disorder

  2023cites this paper
• Prospects and Pitfalls of Plasma Complement C4 in Schizophrenia: Building a Better Biomarker

  2023cites this paper
• Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study

  2023cites this paper
• Study protocol for a randomized controlled trial with rituximab for psychotic disorder in adults (RCT-Rits)

  2023cites this paper
• Changes in Inflammatory Biomarkers in Patients with Schizophrenia: A 3-Year Retrospective Study

  2023cites this paper